Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Overexpression of miR-618 reduced the development of PDCs from CD34+ cells in vitro and enhanced their ability to secrete IFNα, mimicking the PDC phenotype observed in SSc patients. 28556560

2017

Entrez Id: 999
Gene Symbol: CDH1
CDH1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 AlteredExpression BEFREE Among diffuse type GCs, SRCCs showed lower level of methylation for GDNF, RORA, MINT25 and KLF7, and higher level for CDH1 compared to PDCs. 24953529

2014

Entrez Id: 3140
Gene Symbol: MR1
MR1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 GeneticVariation BEFREE Sequencing the whole coding region of PNKD/MR-1 gene identified a heterozygous c.20 C>T (p.Ala7Val) mutation which was clearly segregated in the five affected patients. 22967746

2012

Entrez Id: 3342
Gene Symbol: HTC2
HTC2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Genome wide DNA copy number changes were analyzed by microarray CGH in ACC-HGT, four with transformation into moderately differentiated adenocarcinoma (MDA) and two into poorly differentiated carcinoma (PDC), and five solid ACC. 21541734

2011

Entrez Id: 3342
Gene Symbol: HTC2
HTC2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE genome-wide DNA copy number changes were analyzed by microarray CGH in ACC-HGT, 4 with transformation into moderately differentiated adenocarcinoma (MDA) and two into poorly differentiated carcinoma (PDC), 5 solid ACC. 20978318

2010

Entrez Id: 3140
Gene Symbol: MR1
MR1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Although MR-1 gene function is unknown, the precedence of ion channel disturbance in other episodic neurologic disorders suggests that the pathophysiologic features of PDC also involve abnormal ion localization. 15262732

2004

Entrez Id: 1902
Gene Symbol: LPAR1
LPAR1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE The expression of ATX was highest in MC, while the LPA1 expression was higher in PDC and AC, and the expression of LPA2 and LPA3 was highest in PTC (p < 0.001). 31455351

2019

Entrez Id: 1364
Gene Symbol: CLDN4
CLDN4
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE These findings suggest that targeting CLDN4 might increase the effectiveness and safety of anticancer drug therapy in PDC. 31498559

2019

Entrez Id: 3778
Gene Symbol: KCNMA1
KCNMA1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Emerging evidence suggests the functional BK channel alterations produced by different <i>KCNMA1</i> alleles may associate with semi-distinct patient symptoms, such as paroxysmal nonkinesigenic dyskinesia (PNKD) with GOF and ataxia with LOF. 31427379

2019

Entrez Id: 3845
Gene Symbol: KRAS
KRAS
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Multiple KRAS mutations along with TP53 mutation are genetic markers for C-PDC, which could be detected using pancreatic juice preoperatively. 31404021

2019

Entrez Id: 51284
Gene Symbol: TLR7
TLR7
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE B cell adaptor for PI3K (BCAP) promoted many aspects of TLR7-driven lupus-like disease, including <i>Isg15</i> and <i>Ifit1</i> expression in blood and an immature pDC phenotype associated with higher IFN production. 30936294

2019

Entrez Id: 860
Gene Symbol: RUNX2
RUNX2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE RUNX2 ensures the expression of pDC-signature genes in leukemic cells, but also confers survival and proliferative properties in BPDCN cells. 30971697

2019

Entrez Id: 1072
Gene Symbol: CFL1
CFL1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE UGP2 and CFL1 expression in PDC were positively correlated. 29347944

2018

Entrez Id: 7360
Gene Symbol: UGP2
UGP2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE UGP2 and CFL1 expression in PDC were positively correlated. 29347944

2018

Entrez Id: 929
Gene Symbol: CD14
CD14
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE The experiment lasted for six weeks, and peripheral blood samples were collected from the animals for analyses of selected morphological parameters and changes in the percentages of CD4⁺8<sup>-</sup>, CD4<sup>-</sup>8⁺, and CD4⁺8⁺ lymphocytes and antigen-presenting cells (APC) with CD14⁺172⁺ (monocytes), CD172a<sup>high</sup>4<sup>-</sup>14<sup>-</sup> (conventional dendritic cells, cDC), and CD172a<sup>dim</sup>4⁺14<sup>-</sup> (plasmacytoid dendritic cells, pDC) phenotypes. 28445424

2017

Entrez Id: 7739
Gene Symbol: ZNF185
ZNF185
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE Patients with mZNF185-negative and -positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. 28927124

2017

Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 PosttranslationalModification BEFREE Recently promoter methylation of E-cadherin1 (CDH1) and CDKN2A genes, encoding E-cadherin and P16 respectively, are invoked in development of PDC. 29273724

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE Promoter methylation of both CDH1 and CDKN2A was encountered more frequently in PDC patients with long-DM than non-DM or short DM. 29273724

2017

Entrez Id: 693203
Gene Symbol: MIR618
MIR618
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE Overexpression of miR-618 reduced the development of PDCs from CD34+ cells in vitro and enhanced their ability to secrete IFNα, mimicking the PDC phenotype observed in SSc patients. 28556560

2017

Entrez Id: 1180
Gene Symbol: CLCN1
CLCN1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Clinical features were evaluated, and all subjects were screened for MR-1, SLC2A1, and CLCN1 genes, which are the causative genes of paroxysmal nonkinesigenic dyskinesia (PNKD), paroxysmal exertion-induced dyskinesia, and myotonia congenita (MC), respectively. 27098784

2016

Entrez Id: 3146
Gene Symbol: HMGB1
HMGB1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE In contrast, inhibition of HMGB1 restored pDC phenotype. 25492101

2015

Entrez Id: 8609
Gene Symbol: KLF7
KLF7
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE Among diffuse type GCs, SRCCs showed lower level of methylation for GDNF, RORA, MINT25 and KLF7, and higher level for CDH1 compared to PDCs. 24953529

2014

Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1α, markers of hypoxia, in PDC tissue. 23424623

2013

Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE hENT1 and Notch3 mRNA expressions in EUS-FNA specimens were the key predictive biomarkers of GEM effect and GEM sensitivity in patients with unresectable PDC. 23492684

2013

Entrez Id: 384
Gene Symbol: ARG2
ARG2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1α, markers of hypoxia, in PDC tissue. 23424623

2013